SM
Subhashkumar Mehta
About Subhashkumar Mehta
Data last updated:
Subhashkumar Mehta is a Partner at Sampatti Investment Consultancy Llp (since 2026) and Director at Truviska Pharmaceutical Private Limited (since 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sampatti Investment Consultancy Llp ACZ-2804 | Partner | 26 Jul 2026 | 2026 | Active | |
| Truviska Pharmaceutical Private Limited U46497GJ2025PTC165147 | Director | 17 Jul 2025 | 2025 | Active |
Board colleagues of Subhashkumar Mehta
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subhashkumar Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subhashkumar Mehta
Subhashkumar Mehta currently holds 2 directorships: Sampatti Investment Consultancy Llp (Partner, since 26 Jul 2026); Truviska Pharmaceutical Private Limited (Director, since 17 Jul 2025).
Subhashkumar Mehta was first appointed on 17 Jul 2025 as Director at Truviska Pharmaceutical Private Limited. The most recent appointment on record is 26 Jul 2026 at Sampatti Investment Consultancy Llp.
The current boards of Subhashkumar Mehta's companies include Alpa Mineshbhai Shah (Sampatti Investment Consultancy Llp), Apoorva Nayal (Sampatti Investment Consultancy Llp), Archana Singhania (Sampatti Investment Consultancy Llp), Arjun Pinkal Shah (Sampatti Investment Consultancy Llp), Bharti Chandresh Shah (Sampatti Investment Consultancy Llp), Devarshi Rajeshbhai Patel (Sampatti Investment Consultancy Llp), among others.